期刊文献+

托吡酯治疗癫安全性和耐受性的临床观察 被引量:7

下载PDF
导出
摘要 目的 观察托吡酯在中国人群中的安全性和耐受性。方法 对1999年11月至2000年11月在协和医院癫(?)中心接受托吡酯单和添加治疗的150例癫(?)患者进行观察,总结分析不良反应发生的情况。结果 不良反应大多出现于开始治疗后2个月内,特别是在加量期,以体重减轻最常见,其他不良反应发生率低,并且绝大部分继续治疗后或适当调整药物剂量后消失。其中单药治疗组低于添加治疗组,差异有显著性。结论 在中国人群中,托吡酯安全性和耐受性好,值得推广应用。
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2002年第6期448-450,共3页 Chinese Journal of Nervous and Mental Diseases
  • 相关文献

参考文献2

二级参考文献8

  • 1Lhotoo S D,Epilepsia,2000年,41卷,338页
  • 2Reife R,Epilepsia,2000年,41卷,suppl 1期,S66页
  • 3Sharief M,Viteri C,Ben-Menachem E,et al.Double-blind, placebocontrolled study of topiramate in patients with refractory epilepsy[].Epilepsy Research.1996
  • 4Ben-Menachem E,Henriksen O,DamM,et al.Double-blind, placebocontrolled trial of topiramate as add-on therapy in patients with refractory partial seizures[].Epilepsia.1996
  • 5Tassinari CA,Michelucci R,Chauvel P,et al.Double-blind, placebocontrolled trial of topiramate ( 600 mg daily ) for the treatment of refractory partial epilepsy[].Epilepsia.1996
  • 6Glauser TA.Topiramate[].Seminars in Pediatric Neurology.1997
  • 7Faught E,Wilder BJ,Ramsay RE,et al.Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200, 400, and 600 mg daily dosages[].Neurology.1996
  • 8Privitera M,Fincham R,Penry J,et al.Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600, 800, and 1 000 mg daily dosages[].Neurology.1996

共引文献64

同被引文献30

  • 1唐嶂龙,唐健.癫痫1184例临床分析及随访研究[J].中华全科医学,2003,5(2):109-110. 被引量:8
  • 2史玉泉.实用神经病学.2版.上海:上海科学技术出版社.1978:789-803.
  • 3Harden CL,Kanner AM,Bautista JF,et al.Treatment-refractory epilepsy:an evidence-basedapproach to antiepileptic monotherapy.CNS Spectr,2005,10 (suppl 3):1.
  • 4Karceski S,Morrell M J,Carpenter D.Treatment of epilepsy in adults:expertopinion,2005.Epilepsy Behav,2005,7 (suppl) 1:1.
  • 5French JA,Kanner AM,Bautista J,etal.Efficacy and tolerability of the new antiepileptic drugs Ⅰ:treatment of new onsetepilepsy:report of the Therapeutics and Technology Assessment Subcommittee and QualityStandards Subcommittee of the American Academy of Neurology and the American EpilepsySociety.Neurology,2004,27,62(8):1252.
  • 6Gilliam FG,Veloso F,Bomhof MAM,et al.and the Topiramate EPMN 104 Study Group.Adose-comparison trial of topiramate as monotherapy in recently diagnosed partialepilepsy.Neurology,2003 ;60:196.
  • 7Privitera MD,Brodie M J,Mattson RH,et al.Topiramate,carbamazepine and valproatemonotherapy:double-blind comparison in newly diagnosed epilepsy.Acta Neurol Scand,2003;107 (2):165.
  • 8Arroyo S,Dodson WE,Privitera MD,et al.Randomized dose-controlled study of topiramateas first-line therapy in epilepsy.Acta Neurol Scand,2005,112(4):214.
  • 9Sachdeo R,Beydoun A,Schachter S,et al.Oxcarbazepine (Trileptal) as monotherapy inpatients with partial seizures.Neurology,2001,57 (5):864.
  • 10Groselj J,Guerrini R,Van Oene J,et al.Experience with topiramate monotherapy inelderly patients with recent-onset epilepsy.Acta Neurol Scand,2005,112(3):144.

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部